Labguru

Labguru is a lab management software platform founded in 2008 that specializes in streamlining laboratory operations and data management for the life sciences sector. The company offers an integrated suite of tools including an electronic lab notebook (ELN), laboratory information management system (LIMS), and inventory management in a unified cloud-based platform.

Now part of Cenevo (previously known as Labguru/BioData and Titian Software), Labguru serves 750+ companies worldwide with over 30,000-120,000 scientists using the platform (user counts vary by source). The company maintains a global presence with 80 employees across 5 continents as of August 2024, with headquarters in Massachusetts (Cambridge/Westborough) and Israel.

Labguru is designed specifically for biotech, life sciences, pharmaceutical companies, and academic institutions. The platform emphasizes regulatory compliance with FDA 21 CFR Part 11, GxP, and ALCOA+ standards, making it suitable for companies operating in regulated pharmaceutical and biotechnology environments. The company positions itself as particularly well-suited for startups and growing organizations, offering special rates for startups and academic institutes.

Labguru markets the combination of ELN, LIMS, and inventory management in a single cloud-based system as eliminating the need for multiple vendors and additional integration work. The company offers continuously validated cloud environments for GMP/GDP compliance and provides both shared cloud and dedicated private cloud deployment options for pharmaceutical customers requiring higher security and customization.

Labguru targets biotechnology, life sciences, and pharmaceutical companies as core customer segments within its 750+ company customer base. While the platform serves multiple life science sectors including academic research, it is specifically designed to meet pharmaceutical industry compliance requirements with FDA 21 CFR Part 11, GxP, and ALCOA+ compliance built into the platform.

The company offers validated cloud environments specifically for pharmaceutical manufacturing and biotechnology companies operating under GMP/GDP regulations. Labguru introduced a continuously validated laboratory informatics cloud facilitating biotech and pharma with GMP/GDP compliance. Each customer requesting a validated environment receives a tailored validation plan including execution and documentation of Installation Qualification and Operational Qualification (IQ/OQ) protocols.

Validation and quality assurance procedures were developed to ensure compliance per FDA 21 CFR Part 11, EU Annex 11, and other pharmaceutical regulations. Customers can choose between shared cloud platform with fixed version updates per year or dedicated validated Labguru instance (private cloud) for higher security requirements with ability to adjust validation plan and access to test environment for Performance Qualification (PQ) testing.

Pharmaceutical-specific capabilities include experiments, protocols, and documents as 21 CFR Part 11 compliant documents requiring two-person signature (signature and witnessing). Once signed and witnessed, the ELN auto-generates PDF version locking the date of signature and all associated assets. Electronic signatures are unique to each user and linked to specific records, with audit trails automatically logging changes including timestamps and user details supporting ALCOA+ principles.

The platform is positioned as particularly suitable for growing pharmaceutical and biotech companies, with special pricing for startups that may be in early development stages. Implementing an effective ELN is described as essential for any pharmaceutical lab given the industry's role in creating and producing drugs. Labguru advertises that labs can implement and begin working within days, indicating faster deployment than traditional enterprise LIMS/ELN systems.

While specific named pharmaceutical customers are not publicly disclosed data, the platform serves pharmaceutical companies requiring GMP/GDP compliance, validation documentation, and regulatory-ready electronic signatures and audit trails. The onboarding process has been implemented hundreds of times for pharmaceutical and research customers.

Labguru is a private company with estimated annual revenue between $7.7M-$15M based on 2025 data. Specific estimates include: $7.7M (RocketReach 2025) and $15M (as of August 2024 per another source). As a private company now part of Cenevo, detailed financial information is not publicly disclosed.

The company was founded in 2008 and has grown to serve 750+ companies worldwide with over 30,000-120,000 scientists using the platform. This customer base generates recurring revenue through subscription-based SaaS pricing model, with costs estimated at $1,000-$1,500 per user annually for core ELN and inventory management functionality, plus additional module fees for advanced features.

No external funding rounds or venture capital investment are disclosed. The combination that formed Cenevo (previously Labguru/BioData and Titian Software) is the company's only documented M&A activity; transaction details, valuation, and timing are undisclosed.

Financial health indicators include: 16+ years of continuous operation since 2008, global expansion to 750+ companies and 30,000+ users, 80 employees across 5 continents as of August 2024, and ongoing product development with continuously validated cloud environments for pharmaceutical compliance. No layoffs, restructuring, or financial distress signals are reported.

Revenue model is subscription-based SaaS with pricing that depends on chosen products and modules. Special rates are available for startups and academic institutes, indicating flexible pricing to capture early-stage biotech companies that may grow into larger customers. Implementation costs include training sessions ($1,000-$2,000 per session) and potential customization fees.

Labguru offers a unified, cloud-based all-in-one laboratory management platform combining ELN (Electronic Lab Notebook), LIMS (Laboratory Information Management System), and inventory management in a single integrated solution. This integrated approach eliminates the need to use several systems, avoiding integration issues and the complexity of dealing with multiple vendors.

Core platform components include: ELN for experiment, protocol, and file management with electronic signatures and compliance features; LIMS functionality for sample tracking, data management, and laboratory workflows; Inventory management module for tracking storage locations, QR-code and barcode labels, and optimized ordering; Molecular biology and chemistry notebook modules; and Automation of data processing and workflows.

Deployment model is cloud-based SaaS accessible globally via laptops or mobile devices, eliminating server infrastructure needs. Data is stored in SOC-compliant data centers by Amazon Web Services. Two validated cloud options are available: Shared cloud platform with fixed number of version updates per year scheduled by BioData, with advance notification on upcoming updates and access to test environment for PQ testing; and Dedicated Labguru instance (private cloud) with higher level of security, customizable configuration, adjustable validation plan, and access to test environment for PQ testing.

Compliance and validation capabilities designed for pharmaceutical customers include: FDA 21 CFR Part 11 compliant documents with electronic signatures and witnessing; ALCOA+ compliance with automatic recording of user actions, time-stamped entries, and electronic signatures; Validation documentation including tailored validation plans, IQ/OQ protocols, and PQ testing environments; GMP/GDP compliance for pharmaceutical manufacturing; and EU Annex 11 compliance for European pharmaceutical operations.

Integration capabilities include inventory module connecting with ELN entries, allowing users to add samples and supplies to experiments, track usage and location, create reusable protocols, view all experiments performed on specific samples, and mark stocks as consumed. NetSuite integration available for enterprise lab inventory management. Platform emphasizes workflow automation and mobile accessibility on desktops and mobile devices via cloud.

Implementation is designed for rapid deployment with claims of labs implementing and beginning work within days. Built-in organization systems and workflows come pre-tested and validated for faster implementation than on-premises software. Customization, training, and validation services available to meet lab-specific requirements.

The platform combines ELN, LIMS, and inventory management in one system, is accessible from anywhere via the cloud, offers validated environments for pharmaceutical compliance, has a mobile-responsive design, and is priced for startups and growing companies.

Labguru maintains strategic technology partnerships to support enterprise laboratory operations and regulatory compliance requirements. Key cloud infrastructure partnership includes Amazon Web Services (AWS) with data stored in SOC-compliant data centers, providing secure cloud hosting for the Labguru platform with global accessibility and high availability.

Enterprise integration partnership with NetSuite provides lab inventory management integration for organizations using NetSuite ERP systems, enabling streamlined inventory management workflows between laboratory operations and enterprise financial systems. This integration enhances inventory management capabilities with real-time visibility into inventory levels for informed decision-making.

As part of Cenevo (previously Labguru/BioData and Titian Software), the company benefits from corporate affiliations and potential technology sharing with other Cenevo portfolio companies. However, specific details of Cenevo portfolio synergies or additional partnerships were not publicly disclosed.

Implementation support is provided through combination of Labguru's services team and onboarding process that has been implemented hundreds of times. The company is ready to assist with implementation, customization, training, or other needs to meet lab-specific requirements. Services include validation planning and execution (IQ/OQ protocols), training sessions, and technical support.

The platform's compliance design (FDA 21 CFR Part 11, GxP, EU Annex 11) and pharmaceutical customer base suggest engagement with regulatory standards bodies and pharmaceutical industry stakeholders.

The platform provides integration capabilities through its API, though pre-built integrations with common lab applications or instruments are noted as limited compared to more established LIMS vendors. Integration capabilities include connecting inventory module with ELN entries and NetSuite ERP integration, with additional custom integrations possible through API development.

Labguru provides comprehensive support and professional services tailored to life sciences and pharmaceutical laboratory requirements. The company emphasizes strong customer support with users reporting that the customer support team is very helpful and responsive, and Labguru has a strong team which provides constant support and tight and personal guidance.

Professional services include implementation support with claims of labs able to implement Labguru and begin working within days, faster than traditional enterprise LIMS deployments. The onboarding process has been implemented hundreds of times. Services encompass: customization to meet lab-specific requirements, training sessions ($1,000-$2,000 per session), validation services for pharmaceutical customers including tailored validation plans and IQ/OQ protocol execution and documentation, and technical support for ongoing operations.

For pharmaceutical customers requiring validated environments, Labguru provides dedicated validation services. Each customer who requests a validated environment receives a tailored validation plan that includes initial delivery project with execution and documentation of IQ/OQ protocols. Customers can access test environments for PQ testing purposes to validate system performance before production use.

Cloud-based SaaS delivery model means Labguru manages platform upgrades, security updates, and infrastructure maintenance. The shared cloud platform includes fixed number of version updates per year, scheduled by BioData with advance notification on upcoming updates. Dedicated private cloud customers can adjust update schedules and validation plans to requirements.

Support hours, specific regional coverage, and language coverage are undisclosed. Global presence with employees across 5 continents and 750+ companies worldwide indicates multi-region support capabilities; given the cloud-based nature and global customer base, support is likely provided during business hours across major time zones.

The company maintains a resources hub on the website and provides ongoing guidance to customers as noted in user feedback.

Costs for professional services include training sessions at $1,000-$2,000 per session, with customization costs varying based on requirements. Implementation costs can escalate beyond initial estimates for organizations with complex workflows or extensive integration requirements, with users reporting total costs can increase 200-400% over initial estimates as implementation progresses for complex deployments.

Labguru has operated continuously for 16+ years since its 2008 founding, serving 750+ companies worldwide with over 30,000 users globally (up to 120,000 per some sources).

Regulatory compliance certifications and capabilities include: FDA 21 CFR Part 11 compliance for electronic records and signatures with validation documentation per 21 CFR Part 11, EU Annex 11, and pharmaceutical regulations; GxP compliance with ALCOA+ principles for data integrity; GMP/GDP compliance for pharmaceutical manufacturing environments; and SOC-compliant data centers (Amazon Web Services) for cloud infrastructure security.

The platform has been deployed hundreds of times, according to the company. Validation services include tailored validation plans, IQ/OQ protocol execution and documentation, and access to test environments for PQ testing, critical for pharmaceutical customers operating under regulatory oversight.

User feedback highlights strong customer support and ease of use. Positive themes include: platform at center of day-to-day lab work for lab management and organizing experiments, extremely easy to keep up on team progress with all research at fingertips for preparing manuscripts and presentations, and versatile platform that can be customized depending on organization's needs. User reviews note: "If you're starting a new lab or looking to make the switch over to an electronic notebook and LIMS system, Labguru is worth the investment."

Market positioning emphasizes suitability for startups and growing companies, with special rates available for startups and academic institutes. This positioning targets early-stage biotech and pharmaceutical companies that may expand over time, with company stating: "It's really interesting for young startups to start with LabGuru since it can evolve and adapt to changing needs along with company development."

Labguru is now part of Cenevo (previously Labguru/BioData and Titian Software), which provides corporate stability and potential access to additional resources and development capabilities compared to a standalone vendor.

The company maintains a presence on G2, Capterra, Software Advice, and SourceForge.

Labguru maintains growing market presence in the laboratory informatics sector with 750+ companies worldwide and over 30,000-120,000 scientists using the platform. The company's positioning targets biotechnology, life sciences, pharmaceutical companies, and academic institutions, with particular emphasis on startups and growing organizations through flexible pricing and special rates for startups and academic institutes.

Global market presence includes operations across 5 continents with 80 employees as of August 2024, serving customers worldwide. Headquarters in Massachusetts (Cambridge/Westborough) and Israel provide dual geographic bases for North American and international operations.

The company website includes product information for ELN, LIMS, and inventory management; a pharmaceutical LIMS solutions page; validated cloud environment documentation; an FAQ section; a resources hub with case studies; blog content; and regulatory compliance guides for FDA 21 CFR Part 11, ALCOA+, and GMP/GDP compliance.

Labguru's marketing materials describe the platform as combining ELN, LIMS, and inventory management in one system without the need for multiple vendors, accessible from anywhere via the cloud, offering rapid implementation with claims of days to deployment, validated environments for pharmaceutical compliance, and pricing aimed at early-stage companies with special rates.

Product development has added a continuously validated laboratory informatics cloud for pharmaceutical customers, NetSuite ERP integration for enterprise customers, and both shared cloud and dedicated private cloud deployment options addressing different security and compliance requirements.

Labguru positions itself between higher-priced enterprise LIMS systems and basic laboratory notebook solutions, offering an integrated ELN/LIMS/inventory platform with pharmaceutical compliance at a mid-market price point for growing biotech companies. Users report that integration capabilities are a significant weakness, citing limited pre-built integrations compared to established vendors.

User reviews emphasize customer-support strength and ease of use; some users report technical issues including system bugs, dependency on internet connectivity, and periodic data loss.

Market activity indicators include: continued product development (validated cloud, NetSuite integration), global expansion maintaining operations across 5 continents, growing user base to 30,000+ users, and corporate development through Cenevo formation. No major negative press, financial distress, or significant customer losses are reported.